Skip to main content
Premium Trial:

Request an Annual Quote

The GenomeWeb Design Team

Premium

Paul J. Schindel, GenomeWeb’s creative director and the magazine’s art director, built Genome Technology from scratch a year ago and led the redesign of the current issue. While Paul likes to say that he does a little bit of everything but nothing as well as his staff, we think the slick layout of the Affymetrix cover story this month is testimony to his design talents.

Paul also creates and oversees production of all of GenomeWeb’s corporate marketing materials including our media kits, trade show booths, the GT All-Stars promotions, and our ongoing campaign of ads promoting “New Media for the New Biology.”

Lois Savander, production artist, is responsible for the typesetting and copyfitting of the magazine each month as well as for each of our newsletters. She is the patient soul who corrects all the typos that we editors manage to catch before the magazine goes to press.

John Burrows, graphic designer, is the jack-of-all-trades who designs the magazine’s charts and many of its other visuals. (It was he who put the psychedelic swirl behind Wayne Hendrickson on our September issue cover.) John also designed the BioArray News and ProteoMonitor flags.

Fletcher Grayson, graphic designer, is the creative hand behind many of the layouts and Photoshop effects used on Genome Technology covers and features. He’s the resident Mac guru, and was the lead designer on the GenomeWeb website and the creator of the GenomeWeb logo — both the wrong left-handed one and the right-handed one.

Marla Sansone, production coordinator, arranges photo sessions, tracks ads, and juggles 1,001 details that make or break the monthly magazine and weekly newsletters.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.